This company listing is no longer active
IMRS.Q Stock Overview
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
IMRIS Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -99.98% |
5 Year Change | -99.00% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
IMRS.Q | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | -0.2% | 1.3% |
1Y | n/a | 10.6% | 29.8% |
Return vs Industry: Insufficient data to determine how IMRS.Q performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how IMRS.Q performed against the US Market.
Price Volatility
IMRS.Q volatility | |
---|---|
IMRS.Q Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.8% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.8% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IMRS.Q has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IMRS.Q's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | n/a | Marc Buntaine | https://www.imris.com |
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR).
IMRIS Inc. Fundamentals Summary
IMRS.Q fundamental statistics | |
---|---|
Market cap | US$62.00 |
Earnings (TTM) | -US$30.39m |
Revenue (TTM) | US$28.89m |
0.0x
P/S Ratio0.0x
P/E RatioIs IMRS.Q overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IMRS.Q income statement (TTM) | |
---|---|
Revenue | US$28.89m |
Cost of Revenue | US$18.96m |
Gross Profit | US$9.93m |
Other Expenses | US$40.32m |
Earnings | -US$30.39m |
Last Reported Earnings
Dec 31, 2014
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did IMRS.Q perform over the long term?
See historical performance and comparison